Public Comments

Centers for Medicare & Medicaid Services

RE: CMS 2026 Interoperability Standards and Prior Authorization for Drugs

Connecticut General Assembly, Human Services Committee

RE: Joint Public Comments with HealthHIV to the Connecticut General Assembly on the Proposed Changes to the Medicaid Program

Health Resources & Services Administration

RE: Proposed 340B Rebate Model Pilot Program (HHS Docket No. HRSA-2026-03042)

U.S. Department of Labor
Employee Benefits Security Adm.

RE: Improving Transparency into Pharmacy Benefit Manager Fee Disclosure Proposed Rule (RIN 1210-AB37)

Connecticut General Assembly, Human Services Committee

RE: SB-494, Sections 21 & 22 (340B Program)

New York General Assembly, Senate Committee on Finance

RE: S9007-B, Part W (340B Program)

Centers for Medicare & Medicaid Services

RE: Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program

Florida Department of Health

RE: Joint Public Comments with HealthHIV to the Florida Department of Health on the Proposed Changes to the AIDS Drug Assistance Program

Centers for Medicare & Medicaid Services

RE: Public Submission Form for Information about Selected Drugs and Their Therapeutic Alternatives: BIKTARVEY

Centers for Medicare & Medicaid Services

RE: Guarding U.S. Medicare Against Rising Drug Costs (GUARD) Model [CMS-5546-P]

Centers for Disease Control & Prevention

RE: HIV Data Collection [HHS Docket No. CDC-2025-0519]

Health Resources & Services Administration

RE: 340B Rebate Model Pilot [HHS Docket No. HRSA–2025–14619]

Centers for Medicare & Medicaid Services

RE: CMS Proposed Exclusion of 340B Drug Units from Medicare Inflation Rebate Calculations [CMS-1832-P; RIN 0938-AV50]

Centers for Medicare & Medicaid Services

RE: Medicare Drug Price Negotiation Program Carve-Out Exemption for Medicationas Indicated for the Treatment of HIV/AIDS

New York State Education Department's Office of the Professions' Office of Professional Discipline

RE: Official complaint about City Plus Care Pharmacy Inc.

Centers for Medicare & Medicaid Services

RE: Medicare Drug Price Negotiation Program Draft Guidance

Office of Management & Budget | OMB

RE: RIN: 0906-ZA14 | 340B Rebate Guidance

California General Assembly, Senate Committee on Health

RE: AB 1460 (340B Program)

Texas General Assembly, House Committee on Insurance

RE: HB 3265 (340B Program)

North Carolina Congressional Delegation

RE: Proposed Funding Cuts to HIV Prevention Programs

Colorado General Assembly, Senate Committee on Health & Human Services

RE: SB 124 (340B Program)

Connecticut General Assembly, Joint Committee on Insurance & Real Estate

RE: HB 6870 (Drug Pricing)

Michigan General Assembly, Senate Committee on Oversight

RE: SB 94 (340B Program)

Tennessee General Assembly, Senate Committee on Commerce & Labor

RE: SB 1414 (340B Program)

Tennessee General Assembly, House Committee on Insurance

RE: HB 1242 (340B Program)

Georgia General Assembly, House Committee on Health

RE: HB 139 (340B Program)

Kentucky General Assembly, Senate Committee on Health Services

RE: SB 14 (340B Program)

New York General Assembly, Senate Committee on Health

RE: SB 1913 (340B Program)

Texas HIV Medicine Advisory Committee

RE: Adding Cabenuva to the drug formulary for the Texas AIDS Drug Assistance Program

Connecticut General Assembly, Senate Committee on Human Services

RE: SB 8 (Drug Pricing)

U.S. Senate Bipartisan 340B Working Group

RE: Request for Information – 340B Drug Pricing Program

The Honorable John Bel Edwards, Governor, State of Louisiana

RE: Veto HB 548 (340B Program)

Centers for Medicare & Medicaid Services

RE: CAG-00464N (Apretude)

U.S. Senate, Committee on Health, Education, Labor & Pensions (HELP)

RE: HIV Community Concerns Over S.4395

Health Resources & Services Administration

RE: Needed Update to the Guide for HIV/AIDS Clinical Care for visceral adipose tissue (VAT)

U.S. Department of Health & Human Services

RE: Medicare Part B Drug Payment Model

Centers for Medicare & Medicaid Services

RE: Notice of Benefit and Payment Parameters & Essential Health Benefits

Centers for Medicare & Medicaid Services

RE: Federal Register [FR Doc No: 2014-­‐06081] on the Patient Protection and Affordable Care Act; Third Party Payment of Qualified Health Plan Premiums

Social Security Administration

RE: Federal Register Volume 79, Number 38 [FR Doc No: SSA-­‐2007-­‐0082] on the Revised Medical Criteria for Evaluating HIV Infection and for Evaluating Functional Limitations in Immune System Disorders.

Health Resources & Services Administration

RE: Federal Register Volume 79, Number 2 [FR Doc No: 2013-­‐31473] on the Affordable Care Act (ACA)

Health Resources & Services Administration

RE: Federal Register 77 FR 800: Proposed Data Collection

The White House, Office of National AIDS Policy

RE: ADAP Waiting List Crisis Letter